{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:30:59Z","timestamp":1768285859725,"version":"3.49.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Structural Biology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.sbi.2022.102402","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:11:12Z","timestamp":1652940672000},"page":"102402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Principles of SARS-CoV-2 glycosylation"],"prefix":"10.1016","volume":"75","author":[{"given":"Himanshi","family":"Chawla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-2694","authenticated-orcid":false,"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sbi.2022.102402_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbrc.2020.10.080","article-title":"The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy","volume":"538","author":"Santopolo","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sbi.2022.102402_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nat"},{"key":"10.1016\/j.sbi.2022.102402_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2022.102402_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2022.102402_sref5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.sbi.2022.102402_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib7","doi-asserted-by":"crossref","first-page":"14392","DOI":"10.1021\/acs.analchem.1c01772","article-title":"Suppression of O-linked glycosylation of the SARS-CoV-2 spike by quaternary structural restraints","volume":"93","author":"Eldrid","year":"2021","journal-title":"Anal Chem"},{"key":"10.1016\/j.sbi.2022.102402_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nat"},{"key":"10.1016\/j.sbi.2022.102402_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2022.102402_bib11","first-page":"1544","volume":"vol. 383","author":"Corbett","year":"2020"},{"key":"10.1016\/j.sbi.2022.102402_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.sbi.2022.102402_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nat"},{"key":"10.1016\/j.sbi.2022.102402_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00243-x","article-title":"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses","author":"Bos","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.sbi.2022.102402_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A\u00a0serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.sbi.2022.102402_bib17","first-page":"13349","article-title":"Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva","author":"Faustini","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.sbi.2022.102402_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2022.102402_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the closed SARS-CoV-2 spike trimer","author":"Juraszek","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.sbi.2022.102402_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.chom.2021.02.002","article-title":"Virus vaccines: proteins prefer prolines","volume":"29","author":"Sanders","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.sbi.2022.102402_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/acscentsci.1c00216","article-title":"Molecular aspects concerning the use of the SARS-CoV-2 receptor binding domain as a target for preventive vaccines","volume":"7","author":"Valdes-Balbin","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib24","article-title":"Efficacy and safety of SOBERANA 02, a COVID-19 conjugate vaccine in heterologous three-dose combination","author":"Toledo-Romani","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.sbi.2022.102402_bib25","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1080\/22221751.2020.1821583","article-title":"SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.sbi.2022.102402_bib26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 covid-19 vaccine against the B.1.351 variant","volume":"384","author":"Shinde","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sbi.2022.102402_sref27","doi-asserted-by":"crossref","first-page":"14730","DOI":"10.1021\/acs.analchem.0c03301","article-title":"Comprehensive analysis of the glycan complement of SARS-CoV-2 spike proteins using signature ions-triggered electron-transfer\/higher-energy collisional dissociation (EThcD) mass spectrometry","volume":"92","author":"Wang","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.sbi.2022.102402_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41591-021-01370-1","article-title":"Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19","volume":"276","author":"Ward","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.sbi.2022.102402_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fpls.2021.589940","article-title":"SARS-CoV-2 antigens expressed in plants detect antibody responses in COVID-19 patients","volume":"12","author":"Makatsa","year":"2021","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib30","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1128\/jvi.70.9.6431-6436.1996","article-title":"Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures","volume":"70","author":"Willey","year":"1996","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.sbi.2022.102402_sref31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm0899","article-title":"Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models","author":"Huang","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sbi.2022.102402_bib32","doi-asserted-by":"crossref","first-page":"167332","DOI":"10.1016\/j.jmb.2021.167332","article-title":"Glycosylation and serological reactivity of an expression-enhanced SARS-CoV-2 viral spike mimetic","volume":"434","author":"Chawla","year":"2022","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.sbi.2022.102402_sref33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein","volume":"6","author":"Casalino","year":"2020","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib35","doi-asserted-by":"crossref","first-page":"1005110","DOI":"10.1371\/journal.ppat.1005110","article-title":"Incomplete neutralization and deviation from sigmoidal neutralization curves for HIV broadly neutralizing monoclonal antibodies","volume":"11","author":"Mccoy","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.sbi.2022.102402_bib36","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.sbi.2022.102402_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular architecture of the SARS-CoV-2 virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2022.102402_sref38","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acs.biochem.1c00279","article-title":"Site-specific steric control of SARS-CoV-2 spike glycosylation","volume":"60","author":"Allen","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.sbi.2022.102402_sref39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acscentsci.1c00058","article-title":"Assessing antigen structural integrity through glycosylation analysis of the SARS-CoV-2 viral spike","volume":"7","author":"Brun","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03718-21","article-title":"Inhibition of protein N- glycosylation blocks SARS-CoV-2 infection","author":"Casas-Sanchez","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.sbi.2022.102402_sref41","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41557-021-00758-3","article-title":"A\u00a0glycan gate controls opening of the SARS-CoV-2 spike protein","volume":"1310","author":"Sztain","year":"2021","journal-title":"Nat Chem"},{"key":"10.1016\/j.sbi.2022.102402_bib42","first-page":"9","article-title":"Identification of potential binding sites of sialic acids on the RBD domain of SARS-CoV-2 spike protein","author":"Li","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.sbi.2022.102402_bib43","first-page":"40","article-title":"Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites","author":"Hoffmann","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.sbi.2022.102402_bib45","doi-asserted-by":"crossref","DOI":"10.1039\/D1SC04832E","article-title":"Fine-tuning the spike: role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S","author":"Harbison","year":"2022","journal-title":"Chem Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib46","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1016\/j.cell.2021.07.007","article-title":"A\u00a0selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation","volume":"184","author":"Kang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2022.102402_bib47","article-title":"Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2","author":"Zhang","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.sbi.2022.102402_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10719-015-9641-3","article-title":"N-glycoprotein macroheterogeneity: biological implications and proteomic characterization","volume":"33","author":"Zacchi","year":"2015","journal-title":"Glycoconj J"},{"key":"10.1016\/j.sbi.2022.102402_bib49","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1039\/D1CB00019E","article-title":"Glycan\u2013protein interactions determine kinetics of N-glycan remodeling","volume":"2","author":"Mathew","year":"2021","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.sbi.2022.102402_bib50","article-title":"Glycans on the SARS-CoV-2 spike control the receptor binding domain conformation","author":"Henderson","year":"2020","journal-title":"bioRxiv Prepr Serv Biol"},{"key":"10.1016\/j.sbi.2022.102402_bib51","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/glycob\/cwv058","article-title":"Analysis of site-specific N -glycan remodeling in the endoplasmic reticulum and the Golgi","volume":"25","author":"Hang","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.sbi.2022.102402_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409239709085144","article-title":"Glycosylation: heterogeneity and the 3D structure of proteins","volume":"32","author":"Rudd","year":"1997","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.sbi.2022.102402_sref53","doi-asserted-by":"crossref","first-page":"2109905118","DOI":"10.1073\/pnas.2109905118","article-title":"Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2022.102402_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2022.102402_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2022.102402_bib56","doi-asserted-by":"crossref","first-page":"166762","DOI":"10.1016\/j.jmb.2020.166762","article-title":"Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition","volume":"433","author":"Allen","year":"2021","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.sbi.2022.102402_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.61552","article-title":"Inhibition of SARS-CoV-2 viral entry upon blocking N-and O-glycan elaboration","volume":"9","author":"Yang","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.sbi.2022.102402_bib58","doi-asserted-by":"crossref","first-page":"103712","DOI":"10.1016\/j.ebiom.2021.103712","article-title":"Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in\u00a0vitro","volume":"74","author":"Huang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.sbi.2022.102402_bib59","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2022.102402_bib60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.sbi.2022.102402_bib61","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2022.102402_bib62","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1055\/s-0040-1721319","article-title":"Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin","volume":"120","author":"Mycroft-West","year":"2020","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.sbi.2022.102402_bib63","first-page":"1","article-title":"Sulfated polysaccharides effectively inhibit SARS-CoV-2 in\u00a0vitro","volume":"61","author":"Kwon","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.sbi.2022.102402_bib64","first-page":"81","article-title":"Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2","volume":"181","author":"Nguyen","year":"2021","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.sbi.2022.102402_bib65","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acscentsci.0c00855","article-title":"The SARS-COV-2 spike protein binds sialic acids and enables rapid detection in a lateral flow point of care diagnostic device","volume":"6","author":"Baker","year":"2020","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib66","doi-asserted-by":"crossref","first-page":"23763","DOI":"10.1002\/anie.202011015","article-title":"Structural characterization of N-linked glycans in the receptor binding domain of the SARS-CoV-2 spike protein and their interactions with human lectins","volume":"59","author":"Lenza","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.sbi.2022.102402_bib67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41590-021-01114-w","article-title":"Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules","volume":"23","author":"Stravalaci","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.sbi.2022.102402_bib68","doi-asserted-by":"crossref","first-page":"101507","DOI":"10.1016\/j.jbc.2021.101507","article-title":"The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms","volume":"298","author":"Paiardi","year":"2022","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.sbi.2022.102402_bib69","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.bpj.2021.02.047","article-title":"Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2","volume":"120","author":"Ghorbani","year":"2021","journal-title":"Biophys J"},{"key":"10.1016\/j.sbi.2022.102402_bib70","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A\u00a0neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib71","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","volume":"29","author":"Cerutti","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.sbi.2022.102402_bib72","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms","volume":"370","author":"Tortorici","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.sbi.2022.102402_bib73","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2022.102402_bib74","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2022.102402_bib75","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.str.2017.07.018","article-title":"Microsecond dynamics and network analysis of the HIV-1 SOSIP env trimer reveal collective behavior and conserved microdomains of the glycan shield","volume":"25","author":"Lemmin","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.sbi.2022.102402_bib76","doi-asserted-by":"crossref","first-page":"28014","DOI":"10.1073\/pnas.2000260117","article-title":"Visualization of the HIV-1 Env glycan shield across scales","volume":"117","author":"Berndsen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sbi.2022.102402_bib77","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G","volume":"165","author":"Stewart-Jones","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2022.102402_bib78","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/acscentsci.1c00080","article-title":"Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19\/AZD1222 vaccine","volume":"7","author":"Watanabe","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.sbi.2022.102402_bib79","doi-asserted-by":"crossref","first-page":"50257","DOI":"10.1074\/jbc.M405738200","article-title":"Antigen stability controls antigen presentation","volume":"279","author":"Thai","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.sbi.2022.102402_bib80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1471-4906(01)01976-7","article-title":"Post-translational protein modifications in antigen recognition and autoimmunity","volume":"22","author":"Doyle","year":"2001","journal-title":"Trends Immunol"}],"container-title":["Current Opinion in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X22000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X22000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T20:28:47Z","timestamp":1726345727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X22000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":79,"alternative-id":["S0959440X22000811"],"URL":"https:\/\/doi.org\/10.1016\/j.sbi.2022.102402","relation":{},"ISSN":["0959-440X"],"issn-type":[{"value":"0959-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Principles of SARS-CoV-2 glycosylation","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sbi.2022.102402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102402"}}